REQUEST A DEMO
Total
USD $0.00
Search more companies

MUP Apteka N 278 (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MUP Apteka N 278 Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Russian Download a sample report

MUP Apteka N 278 is an enterprise located in Russia, with the main office in Tuapse. It operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on November 23, 1992. There was a net sales revenue drop of 15.43% reported in MUP Apteka N 278’s latest financial highlights for 2021. There was a total negative growth of 37.32% in MUP Apteka N 278’s total assets over the same period. The net profit margin of MUP Apteka N 278 decreased by 0.81% in 2021.

Headquarters
Gogolya, 6
Tuapse; Krasnodar Krai; Postal Code: 352800

Contact Details: Purchase the MUP Apteka N 278 report to view the information.

Basic Information
Outstanding Shares:
Purchase the MUP Apteka N 278 report to view the information.
Registered Capital:
Purchase the MUP Apteka N 278 report to view the information.
Incorporation Date:
November 23, 1992
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after MUP Apteka N 278 report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-15.43%
Total operating revenue
-15.43%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-79.71%
Total assets
-37.32%
Total equity
-21.86%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.81%
Return on Equity (ROE)
-20.3%
Quick Ratio
-0%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?